RecruitingNCT07617974

Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study

Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study (TRICUSPID-AF)


Sponsor

Centro Cardiologico Monzino

Enrollment

66 participants

Start Date

May 4, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, observational, multicenter study aimed at characterizing tricuspid valve remodeling in patients with atrial fibrillation (AF) without significant tricuspid regurgitation (TR), in relation to AF burden progression.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Consecutive patients with atrial fibrillation (paroxysmal or persistent) undergoing transthoracic echocardiography (TTE) prior to AF ablation with acquisition of a 3D TV dataset.
  • Eligible for enrollment in the control group will be:
  • all consecutive patients with structurally normal hearts and no history of AF or;
  • moderate atrial functional tricuspid regurgitation and AF, in the absence of significant left-sided valvular disease or prior valvular surgery.

Exclusion Criteria5

  • Moderate or greater TR assessed using a multiparametric approach;
  • Arrhythmias other than AF;
  • Prior AF ablations;
  • Rapid ventricular response (average HR >110 bpm) during baseline TTE;
  • Inadequate image quality

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centro Cardiologico Monzino; IRCCS

Milan, Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07617974


Related Trials